Corneal sensitivity after topical bromfenac sodium eye-drop instillation

Clinical Ophthalmology

Volumn 7, Issue , 2013, Pages 741-744

  Yanai, Kaori ^a   Huang, Jane ^a   Kadonosono, Kazuaki ^b   Uchio, Eiichi ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Bromfenac sodium; Cornea; Nonsteroidal anti inflammatory drug; Sensitivity; Tear

Indexed keywords

ARTIFICIAL TEAR; BROMFENAC; EYE DROPS;

ADULT; ARTICLE; BLEPHARITIS; CONTROLLED STUDY; CORNEA; CORNEA DISEASE; DRUG INSTILLATION; DRUG SAFETY; DRUG SENSITIVITY; FEMALE; HEPATITIS; HUMAN; HUMAN EXPERIMENT; LACRIMAL FLUID; LACRIMATION; MALE; NORMAL HUMAN; SCHIRMER TEST; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY;

EID: 84876476344     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S41801     Document Type: Article

References (14)

1. Gupta S, Khurana AK, Ahluwalia BK, Gupta NC. Topical indo methacin for vernal keratoconjunctivitis. Acta Ophthalmol (Copenh). 1991;69:95-98.
2. Laibovitz RA, Koester J, Schaich L, Reaves TA. Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther. 1995;11:361-368.
3. Tauber J, Raizman MB, Ostrov CS, et al. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther. 1998;14:137-145.
4. Ilic J, Gigon S, Leuenberger PM. Comparison of the anti-inflammatory effect of collyria of dexamethasone and diclofenac. Klin Monatsbl Augenheilkd. 1984;184:494-498. French.
5. Friedlaender MH. The current and future therapy of allergic conjunctivitis. Curr Opin Ophthalmol. 1998;9:54-58.
6. Friedlaender M. Overview of ocular allergy treatment. Curr Allergy Asthma Rep. 2001;1:375-379.
7. Sancilio LF, Nolan JC, Wagner LE, Ward JW. The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung. 1987;37:513-519.
8. Miyake-Kashima M, Takano Y, Tanaka M, etal. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. Jpn J Ophthalmol. 2004;48:587-590.
9. Hayasaka Y, Yayasaka S, Zhang X, Nagaki Y. Effects of topical corticosteroids and nonsteroidal anti-inflammatory drugs on prostaglandin E2-induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res. 2003;35:341-344.
10. Asai T, Nakagami T, Mochizuki M, Hata N, Tsuchiya T, Hotta Y. Three cases of Corneal melting after instillation of a new nonsteroidal anti inflammatory drug. Cornea. 2006;25:224-227.
11. Isawi H, Dhaliwal DK. Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use. J Cataract Refract Surg. 2007;33:1644-1646.
12. Szerenyi K, Sorken K, Garbus JJ, Lee M, McDonnell PJ. Decrease in normal human Corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol. 1994;118:312-315.
13. Seitz B, Sorken K, LaBree LD, Garbus JJ, McDonnell PJ. Corneal sensitivity and burning sensation. Comparing topical ketorolac and diclofenac. Arch Ophthalmol. 1996;114:921-924.
14. Moses PL, Schroeder B, Alkhatib O, Ferrentino N, Suppan T, Lidofsky SD. Severe hepatotoxicity associated with bromfenac sodium. Am J Gastroenterol. 1999;94:1393-1396.